Filing Details

Accession Number:
0001181431-11-036810
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-06-15 18:21:40
Reporting Period:
2011-06-15
Filing Date:
2011-06-15
Accepted Time:
2011-06-15 18:21:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178711 Transcept Pharmaceuticals Inc TSPT Pharmaceutical Preparations (2834) 330960223
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1235962 E Marilyn Wortzman C/O Transcept Pharmaceuticals, Inc.
1003 W. Cutting Blvd, Suite 110
Point Richmond CA 94804
Vp, Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-06-15 4,000 $1.77 4,217 No 4 M Direct
Common Stock Disposition 2011-06-15 4,000 $10.11 217 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2011-06-15 4,000 $0.00 4,000 $1.77
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,027 2017-04-04 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2010.
  2. The sale price reported in column 4 of Table 1 represents the weighted average sales price of the shares sold ranging from $10.07 to $10.15 per share. Upon request of the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
  3. One-fourth of the shares subject to the option vested on March 16, 2008 and one forty-eighth of the shares shall vest monthly thereafter.